论文信息 - Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study. - 字舞流文

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.

J. Bourhis | J. Machiels | C. Sire | J. Fayette | S. Henry | J. Kerger | A. Schilf | I. Tennevet | Y. Pointreau | J. Guigay | A. Dillies | S. Zanetta | L. Moal | L. Bozec Le Moal